Crowdfunding the Fight Against Cancer Monday, February 08, 2016 From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
"Gene Fusion" Drives Childhood Brain Cancers Thursday, February 04, 2016 Study co-led by Penn scientists highlights potential targets for future cancer therapies.Cofactor Genomics Acquires Narus Biotechnologies Thursday, February 04, 2016 Cofactor Genomics, a leader in RNA products and applications, announced today that they have acquired San Francisco, CA based Narus Biotechnologies, a biomarker development company focused on creating RNA diagnostic tests for neurological diseases that can help inform therapeutic selection for patients with Multiple Sclerosis, Alzheimer’s and Parkinson’s.£4.4 Million Awarded in Latest SBRI Healthcare Competition Thursday, February 04, 2016 Six companies receive second round of funding to develop high potential innovations.Abbott to Acquire Alere Wednesday, February 03, 2016 Abbott and Alere Inc. have announced a definitive agreement for Abbott to acquire Alere, significantly advancing Abbott's global diagnostics presence and leadership. GenomeFIRST Awarded $400K Grant Wednesday, February 03, 2016 Geisinger Health System has been awarded a $400,000 grant from the Robert Wood Johnson Foundation (RWJF) to support GenomeFIRST Medicine, a unique program to help patients and providers understand and use genomic information in their health care.Head Injury Patients Develop Brain Clumps Associated with Alzheimer’s Disease Wednesday, February 03, 2016 Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.Swift Biosciences, SeraCare Partner Monday, February 01, 2016 Swift Biosciences and SeraCare Life Sciences have announced a partnership to accelerate development of a novel circulating tumor DNA reference material. Abbott to Acquire Alere for $5B Monday, February 01, 2016 Acquisition broadens Abbott's diagnostics footprint by providing access to new product applications, channels and geographies.